Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A12 | P48065 | 3/20 | 0.46 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.46 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 5/20 | 0.45 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16249750 | 0.81 | SLC6A12 (0.54) | SLC6A12SLC6A11SLC6A13GABRR1GABRR2 | |
| SCHEMBL377179 | 0.81 | GABRR1 (0.58) | SLC6A12SLC6A11SLC6A13GABRR1GABRR2 | |
| SCHEMBL25660411 | 0.81 | GABRR1 (0.58) | SLC6A12SLC6A11SLC6A13GABRR1GABRR2 | |
| SCHEMBL25660412 | 0.81 | GABRR1 (0.58) | SLC6A12SLC6A11SLC6A13GABRR1GABRR2 | |
| SCHEMBL4754585 | 0.76 | GABRR1 (0.36) | GABRR1GABRR2 | |
| SCHEMBL143951 | 0.76 | HSD11B1 (0.50) | SLC6A12SLC6A11SLC6A13GABRR1GABRR2 | |
| SCHEMBL8628131 | 0.75 | GABRR1 (0.50) | GABRR1GABRR2SLC1A2MEN1CYP1A2 | |
| SCHEMBL2697233 | 0.75 | GABRR1 (0.50) | GABRR1GABRR2SLC1A2MEN1CYP1A2 | |
| SCHEMBL22039 | 0.75 | GABRR1 (0.50) | GABRR1GABRR2SLC1A2MEN1CYP1A2 | |
| SCHEMBL9782991 | 0.75 | GABRR1 (0.50) | GABRR1GABRR2SLC1A2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6746730-B1 | VARNISH COMPOSITION WHICH COMPRISES POLYMER COMPONENT CONTAINING TWO DIFFERENT POLYAMIC ACIDS, SOLUBLE POLYIMIDE, AND SOLVENT FOR DISSOLVING POLYMER COMPONENT | CHISSO CORPORATION (JP) | 2004-06-08 | — | — | US | claimed |
| US-5244985-A | Epoxidized polyesters and method of production thereof | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1993-09-14 | — | — | US | claimed |
| JP-59170117-A | — | — | None | — | — | JP | disclosed |
| WO-2019176276-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ELEMENT | JSR株式会社 | 2019-09-19 | — | — | WO | disclosed |
| US-7880038-B2 | complexing a tungsten boride and molybdenum boride, a phosphate compound, Mo and W metal, hydrogen peroxide and an amine oxide to form a catalyst, reacting an olefin with H2O2 in the pH 0 to 2 or more, in presence of above catalyst to produce carbonyl compounds by oxidative breaking of C-C bond of olefin | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-01 | — | — | US | disclosed |
| EP-1618953-B1 | USE OF A METAL CATALYST | SUMITOMO CHEMICAL CO (JP) | 2010-12-08 | — | — | EP | disclosed |
| WO-2010011134-A2 | OZONOLYSIS OF AROMATICS AND/OR OLEFINS | DISHMAN PHARMACEUTICALS AND CHEMICALS LTD. (IN) | 2010-01-28 | — | — | WO | disclosed |
| EP-1928936-A1 | PROCESS FOR IMPROVING THE FLOW PROPERTIES OF POLYMER MELTS | Ciba Holding Inc. (CH) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007039471-A1 | PROCESS FOR IMPROVING THE FLOW PROPERTIES OF POLYMER MELTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2007-04-12 | — | — | WO | disclosed |
| US-20060211891-A1 | Metal catalyst and its use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1618953-A1 | METAL CATALYST AND ITS USE | Sumitomo Chemical Company, Limited (JP) | 2006-01-25 | — | — | EP | disclosed |
| EP-1188735-B1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL CO (JP) | 2005-07-27 | — | — | EP | disclosed |
| US-20040152592-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMTED | 2004-08-05 | — | — | US | disclosed |
| US-6746730-B1 | VARNISH COMPOSITION WHICH COMPRISES POLYMER COMPONENT CONTAINING TWO DIFFERENT POLYAMIC ACIDS, SOLUBLE POLYIMIDE, AND SOLVENT FOR DISSOLVING POLYMER COMPONENT | CHISSO CORPORATION (JP) | 2004-06-08 | — | — | US | disclosed |
| US-6703528-B2 | CATALYTIC OXIDATION OF OLEFIN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-03-09 | — | — | US | disclosed |
| EP-1188735-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-20020025906-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-28 | — | — | US | disclosed |
| US-6200655-B1 | MULTILAYER; OPTICAL ELEMENT, POLYIMIDE ALIGNMENT LAYER; LIQUID CRYSTAL | ELSICON, INC. | 2001-03-13 | — | — | US | disclosed |
| US-5244985-A | Epoxidized polyesters and method of production thereof | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| JP-S59170117-A | EPOXY RESIN COMPOSITION | JAPAN SYNTHETIC RUBBER CO LTD | 1984-09-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211891-A1 | Metal catalyst and its use | SOD1, NOX4, MVD | SLC6A12 1922/4885SLC6A11 3313/4885SLC6A13 3287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.